These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease. Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792 [TBL] [Abstract][Full Text] [Related]
10. Are dopaminergic pathways involved in theory of mind? A study in Parkinson's disease. Péron J; Vicente S; Leray E; Drapier S; Drapier D; Cohen R; Biseul I; Rouaud T; Le Jeune F; Sauleau P; Vérin M Neuropsychologia; 2009 Jan; 47(2):406-14. PubMed ID: 18845171 [TBL] [Abstract][Full Text] [Related]
11. Recognition of category-related visual stimuli in Parkinson's disease: before and after pharmacological treatment. Righi S; Viggiano MP; Paganini M; Ramat S; Marini P Neuropsychologia; 2007 Oct; 45(13):2931-41. PubMed ID: 17662314 [TBL] [Abstract][Full Text] [Related]
12. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related]
13. The ability of grafted human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. Nakao N; Shintani-Mizushima A; Kakishita K; Itakura T Exp Neurol; 2004 Jul; 188(1):65-73. PubMed ID: 15191803 [TBL] [Abstract][Full Text] [Related]
14. Neural basis for impaired time reproduction in Parkinson's disease: an fMRI study. Elsinger CL; Rao SM; Zimbelman JL; Reynolds NC; Blindauer KA; Hoffmann RG J Int Neuropsychol Soc; 2003 Nov; 9(7):1088-98. PubMed ID: 14738289 [TBL] [Abstract][Full Text] [Related]
15. Effect of levodopa on healthy volunteers' facial emotion perception: an FMRI study. Delaveau P; Salgado-Pineda P; Wicker B; Micallef-Roll J; Blin O Clin Neuropharmacol; 2005; 28(6):255-61. PubMed ID: 16340378 [TBL] [Abstract][Full Text] [Related]
16. Emotion recognition in patients with idiopathic Parkinson's disease. Yip JT; Lee TM; Ho SL; Tsang KL; Li LS Mov Disord; 2003 Oct; 18(10):1115-22. PubMed ID: 14534914 [TBL] [Abstract][Full Text] [Related]
17. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Ryoo HL; Pierrotti D; Joyce JN Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147 [TBL] [Abstract][Full Text] [Related]
18. Impaired emotion recognition in music in Parkinson's disease. van Tricht MJ; Smeding HM; Speelman JD; Schmand BA Brain Cogn; 2010 Oct; 74(1):58-65. PubMed ID: 20633975 [TBL] [Abstract][Full Text] [Related]
19. Subjective emotional experience at different stages of Parkinson's disease. Vicente S; Péron J; Biseul I; Ory S; Philippot P; Drapier S; Drapier D; Vérin M J Neurol Sci; 2011 Nov; 310(1-2):241-7. PubMed ID: 21741663 [TBL] [Abstract][Full Text] [Related]
20. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Kish SJ; Tong J; Hornykiewicz O; Rajput A; Chang LJ; Guttman M; Furukawa Y Brain; 2008 Jan; 131(Pt 1):120-31. PubMed ID: 17956909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]